2014Chinese Journal of Hospital PharmacyRequires access

Bioequivalence of cefaclor granula in healthy male volunteers

LI Jin-fen

Open publisher page 0 citations

Abstract

OBJECTIVE To evaluate the bioequivalence of cefaclor granules in healthy male volunteers.METHODS In a randomized crossover study,20 healthy male volunteers were given a single oral dose of cefaclor.The serum concentrations of cefaclor before and after administration at different time points were determined by HPLC.The pharmacokinetic parameters were calculated and a statistical analysis using DAS2.0software program.RESULTS The main pharmacokinetic parameters of reference and test preparation tmax,Cmax,AUC05and AUC0∞ were(0.68±0.12)h and(0.68±0.12)h,(12.21±2.80)μg·ml-1 and(11.70±2.65)μg·ml-1,(14.33±3.12)μg·ml-1·h and(13.65±2.72)μg·ml-1·h,(14.58±3.20)μg·ml-1·h and(13.88±2.79)μg·ml-1·h.The statistical analysis showed that the main pharmacokinetic parameters between test and reference preparations were no significant differences.The 90% confidence interval of tested preparations Cmax,AUC05and AUC0∞were 88.3%-104.3%,88.1%-104.6% and 90.1%-102.4%.CONCLUSION The test and reference preparations were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE To evaluate the bioequivalence of cefaclor granules in healthy male volunteers.METHODS In a randomized crossover study,20 healthy male volunteers were given a single oral dose of cefaclor.The serum concentrations of cefaclor before and after administration at different time points were determined by HPLC.The pharmacokinetic parameters were calculated and a statistical analysis using DAS2.0software program.RESULTS The main pharmacokinetic parameters of reference and test preparation tmax,Cmax,AUC05and AUC0∞ were(0.68±0.12)h and(0.68±0.12)h,(12.21±2.80)μg·ml-1 and(11.70±2.65)μg·ml-1,(14.33±3.12)μg·ml-1·h and(13.65±2.72)μg·ml-1·h,(14.58±3.20)μg·ml-1·h and(13.88±2.79)μg·ml-1·h.The statistical analysis showed that the main pharmacokinetic parameters between test and reference preparations were no significant differences.The 90% confidence interval of tested preparations Cmax,AUC05and AUC0∞were 88.3%-104.3%,88.1%-104.6% and 90.1%-102.4%.CONCLUSION The test and reference preparations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To evaluate the bioequivalence of cefaclor granules in healthy male volunteers.METHODS In a randomized crossover study,20 healthy male volunteers were given a single oral dose of cefaclor.The serum concentrations of cefaclor before and after administration at different time points were determined by HPLC.The pharmacokinetic parameters were calculated and a statistical analysis using DAS2.0software program.RESULTS The main pharmacokinetic parameters of reference and test preparation tmax,Cmax,AUC05and AUC0∞ were(0.68±0.12)h and(0.68±0.12)h,(12.21±2.80)μg·ml-1 and(11.70±2.65)μg·ml-1,(14.33±3.12)μg·ml-1·h and(13.65±2.72)μg·ml-1·h,(14.58±3.20)μg·ml-1·h and(13.88±2.79)μg·ml-1·h.The statistical analysis showed that the main pharmacokinetic parameters between test and reference preparations were no significant differences.The 90% confidence interval of tested preparations Cmax,AUC05and AUC0∞were 88.3%-104.3%,88.1%-104.6% and 90.1%-102.4%.CONCLUSION The test and reference preparations were bioequivalent.

Key concepts: Bioequivalence, Cefaclor, Cmax, Pharmacokinetics, Confidence interval, Crossover study, Medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of cefaclor granula in healthy male volunteers — Research Paper | ScholarLens